Two newly synthesized 5-methyltetrahydrofolate-like compounds inhibit methionine synthase activity accompanied by cell cycle arrest in G1/S phase and apoptosis in vitro

Two newly synthesized 5-methyltetrahydrofolate-like compounds inhibit methionine synthase activity accompanied by cell cycle arrest in G1/S phase and apoptosis in vitro
复制标题

DOI:
10.1097/cad.0b013e32830317f2
复制
发表时间:
2008-08-01
期刊:
影响因子:
2.3
通讯作者:
Cui, Jingrong
Cui, Jingrong
中科院分区:
医学4区
文献类型:
--
作者:
Tang, Cai;Zhang, Zhili;Cui, Jingrong

文献摘要

被引文献

相似文献

钴胺素依赖性甲硫氨酸合酶(Cobalamin-dependent methionine synthase,简称GS)是一种以维生素B12为辅助因子的酶,催化5-甲基四氢叶酸(5-methyltetrahydrofolate,简称MTH)与同型半胱氨酸(homocysteine,简称Hcy)反应生成甲硫氨酸和四氢叶酸(methionine and tetrahydrofolate),在叶酸循环、一碳单元转移和含硫氨基酸途径中占据核心地位。“甲基叶酸陷阱”假说表明,蛋氨酸合成酶是一个潜在的抗癌药物开发的目标。ZL 031和ZL 033是新合成的5-甲基四氢叶酸样化合物,作为酶的潜在抑制剂。为了确定这两种化合物对甲硫氨酸合成酶活性的影响,采用分光光度法测定,结果证明ZL 031和ZL 033在HL-60细胞中灭活甲硫氨酸合成酶,IC 50分别为10.0和1.4 μ mol/l。此外,观察到明显的抑制HL-60细胞增殖的作用,导致我们进一步探讨其潜在的抗癌机制。在甲硫氨酸合成酶缺乏和随后叶酸耗竭的情况下,细胞周期被阻滞在G1/S期,并观察到凋亡。细胞周期调控蛋白分析表明,细胞周期蛋白E和细胞周期蛋白依赖性激酶2都增加。此外,还观察到caspase-3、聚(ADP-核糖)聚合酶、caspase-8和caspase-9蛋白水平降低。在我们进行的所有生物学实验中,ZL 033显示出比ZL 031更好的功效。上述结果表明,ZL 031和ZL 033作为一种新型的蛋氨酸合成酶抑制剂,在体外可引起HL-60细胞G1/S期延迟和凋亡,并最终抑制HL-60细胞的增殖。羧酸取代的ZL 033可能比酯取代的ZL 031具有更好的药物开发潜力。
Cobalamin-dependent methionine synthase, with a cofactor of vitamin B12, catalyzes the reaction of 5-methyltetrahydrofolate and homocysteine to form methionine and tetrahydrofolate, which takes a core position in folate cycle, one-carbon-unit transfer, and sulfur amino acid pathways. The 'methyl folate trap' hypothesis suggests that methionine synthase is a potential target for anticancer drug development. ZL031 and ZL033 are 5-methyltetrahydrofolate-like compounds that have been newly synthesized as potential inhibitors of the enzyme. To identify the effect of these two compounds on methionine synthase activity, a spectrophotometric assay was used and the results proved that ZL031 and ZL033 inactivated methionine synthase in HL-60 cells with an IC50 dose of 10.0 and 1.4 mu mol/l, respectively. Moreover, obvious inhibitory effect on proliferation of HL-60 cells was observed, leading to our further investigation of the underlying anticancer mechanism. Under the circumstances of methionine synthase deficiency and subsequent folate depletion, cell cycle was arrested in G1/S phase and apoptosis was also observed. Analysis of cell cycle regulatory proteins demonstrated that cyclin E and cyclin-dependent kinase 2 were both increased. Furthermore, reduction of caspase-3, poly (ADP-ribose) polymerase, caspase-8, and caspase-9 protein levels were observed. In all the biological experiments we have performed, ZL033 has shown a better efficacy compared with ZL031. These results suggest that ZL031 and ZL033, as novel methionine synthase inhibitors, caused G1/S phase delay and apoptosis and eventually inhibit the proliferation of HL-60 cells in vitro. ZL033, with a carboxylic acid substituent, might have a better potential for drug development than ZL031 with an ester substituent.